Search

Your search keyword '"Underwood, Fox E."' showing total 143 results
Start Over Author "Underwood, Fox E."
143 results on '"Underwood, Fox E."'

2. Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses

Author

Buie, Michael J., Quan, Joshua, Windsor, Joseph W., Coward, Stephanie, Hansen, Tawnya M., King, James A., Kotze, Paulo G., Gearry, Richard B., Ng, Siew C., Mak, Joyce W.Y., Abreu, Maria T., Rubin, David T., Bernstein, Charles N., Banerjee, Rupa, Yamamoto-Furusho, Jesus K., Panaccione, Remo, Seow, Cynthia H., Ma, Christopher, Underwood, Fox E., Ahuja, Vineet, Panaccione, Nicola, Shaheen, Abdel-Aziz, Holroyd-Leduc, Jayna, Kaplan, Gilaad G., Balderramo, Domingo, Chong, Vui Heng, Juliao-Baños, Fabián, Dutta, Usha, Simadibrata, Marcellus, Kaibullayeva, Jamilya, Sun, Yang, Hilmi, Ida, Raja Ali, Raja Affendi, Paudel, Mukesh Sharma, Altuwaijri, Mansour, Hartono, Juanda Leo, Wei, Shu Chen, Limsrivilai, Julajak, El Ouali, Sara, Vergara, Beatriz Iade, Dao, Viet Hang, Kelly, Paul, Hodges, Phoebe, Miao, Yinglei, and Li, Maojuan

Published
2023
Full Text
View/download PDF

3. Variation in Testing for and Incidence of Celiac Autoimmunity in Canada: A Population-Based Study

Author

King, James A., Bakal, Jeffrey A., Li, Bing, Whitten, Tara A., Gidrewicz, Dominica, Turner, Justine M., van Zanten, Sander Veldhuyzen, Huynh, Hien Q., Heitman, Steven J., Shaheen, Abdel Aziz, Quan, Hude, Godley, Jenny, Underwood, Fox E., Hracs, Lindsay, Bergman, David, Ludvigsson, Jonas F., Lebwohl, Benjamin, Benchimol, Eric I., Williamson, Tyler, and Kaplan, Gilaad G.

Published
2023
Full Text
View/download PDF

8. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

Author

Brenner, Erica J., Ungaro, Ryan C., Gearry, Richard B., Kaplan, Gilaad G., Kissous-Hunt, Michele, Lewis, James D., Ng, Siew C., Rahier, Jean-Francois, Reinisch, Walter, Ruemmele, Frank M., Steinwurz, Flavio, Underwood, Fox E., Zhang, Xian, Colombel, Jean-Frederic, and Kappelman, Michael D.

Published
2020
Full Text
View/download PDF

10. Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development

Author

King, James A, Underwood, Fox E, Panaccione, Nicola, Quan, Josh, Windsor, Joseph W, Kotze, Paulo G, Ng, Siew C, Ghosh, Subrata, Lakatos, Peter L, Jess, Tine, Panaccione, Remo, Seow, Cynthia H, Ben-Horin, Shomron, Burisch, Johan, Colombel, Jean-Frédéric, Loftus, Edward V, Jr, Gearry, Richard, Halfvarson, Jonas, and Kaplan, Gilaad G

Published
2019
Full Text
View/download PDF

15. Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses

Author

Buie, Michael J., primary, Quan, Joshua, additional, Windsor, Joseph W., additional, Coward, Stephanie, additional, Hansen, Tawnya M., additional, King, James A., additional, Kotze, Paulo G., additional, Gearry, Richard B., additional, Ng, Siew C., additional, Mak, Joyce W.Y., additional, Abreu, Maria T., additional, Rubin, David T., additional, Bernstein, Charles N., additional, Banerjee, Rupa, additional, Yamamoto-Furusho, Jesus K., additional, Panaccione, Remo, additional, Seow, Cynthia H., additional, Ma, Christopher, additional, Underwood, Fox E., additional, Ahuja, Vineet, additional, Panaccione, Nicola, additional, Shaheen, Abdel-Aziz, additional, Holroyd-Leduc, Jayna, additional, Kaplan, Gilaad G., additional, Balderramo, Domingo, additional, Chong, Vui Heng, additional, Juliao-Baños, Fabián, additional, Dutta, Usha, additional, Simadibrata, Marcellus, additional, Kaibullayeva, Jamilya, additional, Sun, Yang, additional, Hilmi, Ida, additional, Raja Ali, Raja Affendi, additional, Paudel, Mukesh Sharma, additional, Altuwaijri, Mansour, additional, Hartono, Juanda Leo, additional, Wei, Shu Chen, additional, Limsrivilai, Julajak, additional, El Ouali, Sara, additional, Vergara, Beatriz Iade, additional, Dao, Viet Hang, additional, Kelly, Paul, additional, Hodges, Phoebe, additional, Miao, Yinglei, additional, and Li, Maojuan, additional

Published
2022
Full Text
View/download PDF

16. The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis.

Author

UCL - (MGD) Service de gastro-entérologie, UCL - SSS/IREC/MONT - Pôle Mont Godinne, Kaplan, Gilaad G, Underwood, Fox E, Coward, Stephanie, Agrawal, Manasi, Ungaro, Ryan C, Brenner, Erica J, Gearry, Richard B, Kissous-Hunt, Michele, Lewis, James D, Ng, Siew C, Rahier, Jean-François, Reinisch, Walter, Steinwurz, Flavio, Zhang, Xian, Kappelman, Michael D, Colombel, Jean-Frederic, UCL - (MGD) Service de gastro-entérologie, UCL - SSS/IREC/MONT - Pôle Mont Godinne, Kaplan, Gilaad G, Underwood, Fox E, Coward, Stephanie, Agrawal, Manasi, Ungaro, Ryan C, Brenner, Erica J, Gearry, Richard B, Kissous-Hunt, Michele, Lewis, James D, Ng, Siew C, Rahier, Jean-François, Reinisch, Walter, Steinwurz, Flavio, Zhang, Xian, Kappelman, Michael D, and Colombel, Jean-Frederic

Abstract

Cases of coronavirus disease 2019 (COVID-19) have emerged in discrete waves. We explored temporal trends in the reporting of COVID-19 in inflammatory bowel disease (IBD) patients. The Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) is an international registry of IBD patients diagnosed with COVID-19. The average percent changes (APCs) were calculated in weekly reported cases of COVID-19 during the periods of March 22 to September 12, September 13 to December 12, 2020, and December 13 to July 31, 2021. Across 73 countries, 6404 cases of COVID-19 were reported in IBD patients. COVID-19 reporting decreased globally by 4.2% per week (95% CI, -5.3% to -3.0%) from March 22 to September 12, 2020, then climbed by 10.2% per week (95% CI, 8.1%-12.3%) from September 13 to December 12, 2020, and then declined by 6.3% per week (95% CI, -7.8% to -4.7%). In the fall of 2020, weekly reporting climbed in North America (APC, 11.3%; 95% CI, 8.8-13.8) and Europe (APC, 17.7%; 95% CI, 12.1%-23.5%), whereas reporting was stable in Asia (APC, -8.1%; 95% CI, -15.6-0.1). From December 13, 2020, to July 31, 2021, reporting of COVID-19 in those with IBD declined in North America (APC, -8.5%; 95% CI, -10.2 to -6.7) and Europe (APC, -5.4%; 95% CI, -7.2 to -3.6) and was stable in Latin America (APC, -1.5%; 95% CI, -3.5% to 0.6%). Temporal trends in reporting of COVID-19 in those with IBD are consistent with the epidemiological patterns COVID-19 globally.

Published
2022

17. The Global Incidence of Peptic Ulcer Disease Is Decreasing Since the Turn of the 21st Century: A Study of the Organisation for Economic Co-Operation and Development (OECD)

Author

Azhari, Hassan, primary, King, James A., additional, Coward, Stephanie, additional, Windsor, Joseph W., additional, Ma, Christopher, additional, Shah, Shailja C., additional, Ng, Siew C., additional, Mak, Joyce W.Y., additional, Kotze, Paulo G., additional, Ben-Horin, Shomron, additional, Loftus, Edward V., additional, Lees, Charlie W., additional, Gearry, Richard, additional, Burisch, Johan, additional, Lakatos, Peter L., additional, Calvet, Xavier, additional, Bosques Padilla, Francisco Javier, additional, Underwood, Fox E., additional, and Kaplan, Gilaad G., additional

Published
2022
Full Text
View/download PDF

18. Sa1556: GLOBAL HOSPITALIZATION TRENDS FOR FLARING CROHN'S DISEASE AND ULCERATIVE COLITIS: SYSTEMATIC REVIEW WITH TEMPORAL ANALYSES

Author

Buie, Michael J., primary, Quan, Joshua, additional, Windsor, Joseph W., additional, Coward, Stephanie, additional, Gearry, Richard, additional, Hansen, Tawnya, additional, King, James A., additional, Kotze, Paulo G., additional, Ng, Siew C., additional, Mak, Joyce W., additional, Abreu, Maria T., additional, Rubin, David T., additional, Bernstein, Charles N., additional, Banerjee, Rupa, additional, Panaccione, Remo, additional, Seow, Cynthia H., additional, Underwood, Fox E., additional, Shaheen, Abdel A., additional, Holroyd-Leduc, Jayna, additional, and Kaplan, Gilaad, additional

Published
2022
Full Text
View/download PDF

19. The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis

Author

Kaplan, Gilaad G, primary, Underwood, Fox E, additional, Coward, Stephanie, additional, Agrawal, Manasi, additional, Ungaro, Ryan C, additional, Brenner, Erica J, additional, Gearry, Richard B,, additional, Kissous-Hunt, Michele, additional, Lewis, James D, additional, Ng, Siew C, additional, Rahier, Jean-Francois, additional, Reinisch, Walter, additional, Steinwurz, Flavio, additional, Zhang, Xian, additional, Kappelman, Michael D, additional, and Colombel, Jean-Frederic, additional

Published
2022
Full Text
View/download PDF

22. Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry

Author

Agrawal, Manasi, Brenner, Erica J, Zhang, Xian, Colombel, Jean-Frederic, Kappelman, Michael D, Ungaro, Ryan C, SECURE-IBD Advisory Committee including, Gearry, Richard B, Kalpan, Gilaad G, Kissous-Hunt, Michele, Lewis, James D, Ng, Siew C, Rahier, Jean-François, Reinisch, Walter, Ruemmele, Frank M, Steinwurz, Flavio, Underwood, Fox E, UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie, and UCL - (MGD) Service de gastro-entérologie

Subjects
Adult, Male, Crohn’s disease, medicine.medical_specialty, Integrins, Short Report, Disease, Inflammatory bowel disease, digestive system, coronavirus disease 2019, inflammatory bowel disease, Internal medicine, IBD therapy, Epidemiology, medicine, Humans, Immunologic Factors, Registries, Medical prescription, Practice Patterns, Physicians', Glucocorticoids, AcademicSubjects/MED00260, ulcerative colitis, Crohn's disease, Coronavirus disease 2019, business.industry, Anti-Inflammatory Agents, Non-Steroidal, Gastroenterology, COVID-19, Odds ratio, General Medicine, medicine.disease, Inflammatory Bowel Diseases, Ulcerative colitis, Confidence interval, digestive system diseases, Female, Tumor Necrosis Factor Inhibitors, business
Abstract

Background We aimed to describe physician practice patterns in holding or continuing IBD therapy in the setting of COVID-19 infection, using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease [SECURE-IBD] registry. Methods IBD medications that were stopped due to COVID-19 were recorded in the SECURE-IBD registry in addition to demographic and clinical data. We conducted descriptive analyses to understand characteristics associated with stopping IBD medications in response to active COVID-19 infection. Results Of 1499 patients, IBD medications were stopped in 518 [34.6%] patients. On bivariate and multivariable analyses, a diagnosis of ulcerative colitis or IBD-unspecified was associated with a lower odds of stopping medication compared with Crohn’s disease (adjusted odds ratio [aOR] 0.6, 95% confidence interval [CI] 0.48, 0.75). When evaluating specific medications, 5-aminosalicylic acid was more likely to be continued [p Conclusions IBD medications other than immunomodulators were continued in the majority of IBD patients with COVID-19, in the international SECURE-IBD registry. Future studies are needed to understand the impact of stopping or continuing IBD medications on IBD- and COVID-19 related outcomes.

Published
2021

23. Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry.

Author

UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie, UCL - (MGD) Service de gastro-entérologie, Agrawal, Manasi, Brenner, Erica J, Zhang, Xian, Colombel, Jean-Frederic, Kappelman, Michael D, Ungaro, Ryan C, SECURE-IBD Advisory Committee including, Gearry, Richard B, Kalpan, Gilaad G, Kissous-Hunt, Michele, Lewis, James D, Ng, Siew C, Rahier, Jean-François, Reinisch, Walter, Ruemmele, Frank M, Steinwurz, Flavio, Underwood, Fox E, UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie, UCL - (MGD) Service de gastro-entérologie, Agrawal, Manasi, Brenner, Erica J, Zhang, Xian, Colombel, Jean-Frederic, Kappelman, Michael D, Ungaro, Ryan C, SECURE-IBD Advisory Committee including, Gearry, Richard B, Kalpan, Gilaad G, Kissous-Hunt, Michele, Lewis, James D, Ng, Siew C, Rahier, Jean-François, Reinisch, Walter, Ruemmele, Frank M, Steinwurz, Flavio, and Underwood, Fox E

Abstract

We aimed to describe physician practice patterns in holding or continuing IBD therapy in the setting of COVID-19 infection, using the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease [SECURE-IBD] registry. IBD medications that were stopped due to COVID-19 were recorded in the SECURE-IBD registry in addition to demographic and clinical data. We conducted descriptive analyses to understand characteristics associated with stopping IBD medications in response to active COVID-19 infection. Of 1499 patients, IBD medications were stopped in 518 [34.6%] patients. On bivariate and multivariable analyses, a diagnosis of ulcerative colitis or IBD-unspecified was associated with a lower odds of stopping medication compared with Crohn's disease (adjusted odds ratio [aOR] 0.6, 95% confidence interval [CI] 0.48, 0.75). When evaluating specific medications, 5-aminosalicylic acid was more likely to be continued [p <0.001] whereas anti-tumour necrosis factor therapy and immunomodulator therapy were more likely to be stopped [global p <0.001]. Other demographic and clinical characteristics did not affect prescription patterns. IBD medications other than immunomodulators were continued in the majority of IBD patients with COVID-19, in the international SECURE-IBD registry. Future studies are needed to understand the impact of stopping or continuing IBD medications on IBD- and COVID-19 related outcomes.

Published
2021

24. Sa506 GLOBAL HOSPITALIZATION TRENDS FOR CROHN'S DISEASE AND ULCERATIVE COLITIS: SYSTEMATIC REVIEW WITH TEMPORAL ANALYSES

Author

Buie, Michael, primary, Quan, Joshua, additional, Windsor, Joseph W., additional, Coward, Stephanie, additional, Gearry, Richard, additional, Hansen, Tawnya, additional, King, James A., additional, Kotze, Paulo G., additional, Ng, Siew C., additional, Panaccione, Remo, additional, Seow, Cynthia H., additional, Underwood, Fox E., additional, and Kaplan, Gilaad, additional

Published
2021
Full Text
View/download PDF

25. Sa280 THE GLOBAL INCIDENCE OF ACUTE PANCREATITIS IS INCREASING OVER TIME: A SYSTEMATIC REVIEW AND META-ANALYSIS

Author

Iannuzzi, Jordan P., primary, Leong, Jessica, additional, Quan, Joshua, additional, King, James A., additional, Windsor, Joseph W., additional, Tanyingoh, Divine, additional, Coward, Stephanie, additional, Forbes, Nauzer, additional, Heitman, Steven J., additional, Buie, Michael, additional, Underwood, Fox E., additional, and Kaplan, Gilaad, additional

Published
2021
Full Text
View/download PDF

26. Fr231 VARIATION IN TISSUE TRANSGLUTAMINASE TESTING AND THE INCIDENCE OF CELIAC DISEASE AUTOIMMUNITY: A POPULATION-BASED STUDY IN ALBERTA, CANADA

Author

King, James A., primary, Bakal, Jeffrey, additional, Li, Bing, additional, Whitten, Tara, additional, Gidrewicz, Dominica, additional, Turner, Justine, additional, Van Zanten, Sander Veldhuyzen, additional, Huynh, Hien Q., additional, Heitman, Steven J., additional, Shaheen, Abdel Aziz, additional, Quan, Hude, additional, Godley, Jenny, additional, Underwood, Fox E., additional, Bergman, David, additional, Lebwohl, Benjamin, additional, Ludvigsson, Jonas F., additional, and Kaplan, Gilaad, additional

Published
2021
Full Text
View/download PDF

27. Sa502 THE FIRST AND SECOND WAVE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A TEMPORAL TREND ANALYSIS

Author

Kaplan, Gilaad, primary, Underwood, Fox E., additional, Tanyingoh, Divine, additional, Agrawal, Manasi, additional, Ungaro, Ryan C., additional, Brenner, Erica J., additional, Gearry, Richard, additional, Kissous-Hunt, Michele, additional, Lewis, James D., additional, Ng, Siew C., additional, Rahier, Jean-Francois, additional, Reinisch, Walter, additional, Steinwurz, Flavio, additional, Zhang, Xian, additional, Kappelman, Michael, additional, and Colombel, Jean Frederic, additional

Published
2021
Full Text
View/download PDF

29. Incidence of Celiac Disease Is Increasing Over Time : A Systematic Review and Meta-analysis

Author

King, James A., Jeong, Jocelyn, Underwood, Fox E., Quan, Joshua, Panaccione, Nicola, Windsor, Joseph W., Coward, Stephanie, deBruyn, Jennifer, Ronksley, Paul E., Shaheen, Abdel-Aziz, Quan, Hude, Godley, Jenny, Veldhuyzen van Zanten, Sander, Lebwohl, Benjamin, Ng, Siew C., Ludvigsson, Jonas F., Kaplan, Gilaad G., King, James A., Jeong, Jocelyn, Underwood, Fox E., Quan, Joshua, Panaccione, Nicola, Windsor, Joseph W., Coward, Stephanie, deBruyn, Jennifer, Ronksley, Paul E., Shaheen, Abdel-Aziz, Quan, Hude, Godley, Jenny, Veldhuyzen van Zanten, Sander, Lebwohl, Benjamin, Ng, Siew C., Ludvigsson, Jonas F., and Kaplan, Gilaad G.

Abstract

OBJECTIVES: To conduct a systematic review and meta-analysis that defines the worldwide incidence of celiac disease (CD) and examines temporal trends. METHODS: MEDLINE and EMBASE were searched for population-based studies reporting the incidence of CD in the overall population, children, or adults. No limits were placed on year or language of publication. Studies solely examining at-risk populations (e.g., patients with type 1 diabetes) were excluded. Random-effects models were performed to meta-analyze sex- and age-specific incidence in the 21st century. Temporal trend analyses assessed the average annual percent change in CD incidence over time. RESULTS: Of 11,189 citations, 86 eligible studies were identified for inclusion, of which 50 were deemed suitable for analyses. In the 21st century, the pooled female incidence of CD was 17.4 (95% confidence interval [CI]: 13.7, 21.1) (I-2= 99.5%) per 100,000 person-years, compared with 7.8 (95% CI: 6.3, 9.2) (I-2= 98.6%) in males. Child-specific incidence was 21.3 per 100,000 person-years (95% CI: 15.9, 26.7) (I-2= 99.7%) compared with 12.9 (95% CI: 7.6, 18.2) (I-2= 99.9%) in adults. Pooling average annual percent changes showed the incidence of CD to be increasing by 7.5% (95% CI: 5.8, 9.3) (I-2= 79.6%) per year over the past several decades. DISCUSSION: Incidence of CD is highest in females and children. Overall, the incidence has been significantly rising in the latter half of the 20th century and into the 21st century throughout the Western world. Population-based studies in Africa, Asia, and Latin America are needed to provide a comprehensive picture of the global incidence of CD., Funding Agencies:Canadian Celiac Association Digestive Strategic Clinical Network (DHSCN) of Alberta Health Services (AHS)

Published
2020
Full Text
View/download PDF

30. Effect of IBD medications on COVID-19 outcomes: results from an international registry

Author

Ungaro, Ryan C, primary, Brenner, Erica J, additional, Gearry, Richard B, additional, Kaplan, Gilaad G, additional, Kissous-Hunt, Michele, additional, Lewis, James D, additional, Ng, Siew C, additional, Rahier, Jean-Francois, additional, Reinisch, Walter, additional, Steinwurz, Flávio, additional, Underwood, Fox E, additional, Zhang, Xian, additional, Colombel, Jean-Frederic, additional, and Kappelman, Michael D, additional

Published
2020
Full Text
View/download PDF

32. Incidence of Celiac Disease Is Increasing Over Time: A Systematic Review and Meta-analysis

Author

King, James A., primary, Jeong, Jocelyn, additional, Underwood, Fox E., additional, Quan, Joshua, additional, Panaccione, Nicola, additional, Windsor, Joseph W., additional, Coward, Stephanie, additional, deBruyn, Jennifer, additional, Ronksley, Paul E., additional, Shaheen, Abdel-Aziz, additional, Quan, Hude, additional, Godley, Jenny, additional, Veldhuyzen van Zanten, Sander, additional, Lebwohl, Benjamin, additional, Ng, Siew C., additional, Ludvigsson, Jonas F., additional, and Kaplan, Gilaad G., additional

Published
2020
Full Text
View/download PDF

33. Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries : a population-based study of countries in the Organisation for Economic Co-operation and Development

Author

King, James A., Underwood, Fox E., Panaccione, Nicola, Quan, Josh, Windsor, Joseph W., Kotze, Paulo G., Ng, Siew C., Ghosh, Subrata, Lakatos, Peter L., Jess, Tine, Panaccione, Remo, Seow, Cynthia H., Ben-Horin, Shomron, Burisch, Johan, Colombel, Jean-Frederic, Loftus, Edward V., Jr., Gearry, Richard, Halfvarson, Jonas, Kaplan, Gilaad G., King, James A., Underwood, Fox E., Panaccione, Nicola, Quan, Josh, Windsor, Joseph W., Kotze, Paulo G., Ng, Siew C., Ghosh, Subrata, Lakatos, Peter L., Jess, Tine, Panaccione, Remo, Seow, Cynthia H., Ben-Horin, Shomron, Burisch, Johan, Colombel, Jean-Frederic, Loftus, Edward V., Jr., Gearry, Richard, Halfvarson, Jonas, and Kaplan, Gilaad G.

Abstract

Background: Hospitalisation rates for inflammatory bowel disease (IBD) vary across the world. We aimed to investigate temporal patterns of hospitalisation for IBD in member countries of the Organisation for Economic Co-operation and Development (OECD). Methods: From the OECD database, we assessed IBD-related hospitalisation rates (expressed as annual rates per 100 000 inhabitants) for 34 countries from 1990 to 2016. We calculated mean hospitalisation rates for the period 2010-15 and used joinpoint regression models to calculate average annual percentage changes with 95% CIs. Findings: Mean hospitalisation rates for IBD from 2010 to 2015 were highest in North America (eg, 33.9 per 100 000 in the USA), Europe (eg, 72.9 per 100 000 in Austria), and Oceania (eg, 31.5 per 100 000 in Australia). Hospitalisation rates for IBD were stabilising or decreasing over time in many countries in these regions but increasing in others. Countries in Asia and Latin America and the Caribbean had the lowest IBD-related hospitalisation rates but the greatest increases in rates over time. For example, Turkey had an annual hospitalisation rate of 10.8 per 100 000 inhabitants and an average annual percentage change of 10.4% (95% CI 5.2-15.9). Similarly, Chile had an annual hospitalisation rate of 9.0 per 100 000 inhabitants and an average annual percentage change of 5.9% (4.9-7.0). Interpretation: Hospitalisation rates for IBD are high in western countries but are typically stabilising or decreasing, whereas rates in many newly industrialised countries are rapidly increasing, which reflects the known increase in IBD prevalence in these countries. Potential explanations for these trends include changes in the epidemiology of IBD, health-care delivery, and infrastructure in these countries, as well as overall country-specific patterns in hospitalisations and differences between countries in data collection methods.

Published
2019
Full Text
View/download PDF

34. Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries:a population-based study of countries in the Organisation for Economic Co-operation and Development

Author

King, James A., Underwood, Fox E., Panaccione, Nicola, Quan, Josh, Windsor, Joseph W., Kotze, Paulo G., Ng, Siew C., Ghosh, Subrata, Lakatos, Peter L., Jess, Tine, Panaccione, Remo, Seow, Cynthia H., Ben-Horin, Shomron, Burisch, Johan, Colombel, Jean Frédéric, Loftus, Edward V., Gearry, Richard, Halfvarson, Jonas, Kaplan, Gilaad G., King, James A., Underwood, Fox E., Panaccione, Nicola, Quan, Josh, Windsor, Joseph W., Kotze, Paulo G., Ng, Siew C., Ghosh, Subrata, Lakatos, Peter L., Jess, Tine, Panaccione, Remo, Seow, Cynthia H., Ben-Horin, Shomron, Burisch, Johan, Colombel, Jean Frédéric, Loftus, Edward V., Gearry, Richard, Halfvarson, Jonas, and Kaplan, Gilaad G.

Abstract

Background: Hospitalisation rates for inflammatory bowel disease (IBD) vary across the world. We aimed to investigate temporal patterns of hospitalisation for IBD in member countries of the Organisation for Economic Co-operation and Development (OECD). Methods: From the OECD database, we assessed IBD-related hospitalisation rates (expressed as annual rates per 100 000 inhabitants) for 34 countries from 1990 to 2016. We calculated mean hospitalisation rates for the period 2010–15 and used joinpoint regression models to calculate average annual percentage changes with 95% CIs. Findings: Mean hospitalisation rates for IBD from 2010 to 2015 were highest in North America (eg, 33·9 per 100 000 in the USA), Europe (eg, 72·9 per 100 000 in Austria), and Oceania (eg, 31·5 per 100 000 in Australia). Hospitalisation rates for IBD were stabilising or decreasing over time in many countries in these regions but increasing in others. Countries in Asia and Latin America and the Caribbean had the lowest IBD-related hospitalisation rates but the greatest increases in rates over time. For example, Turkey had an annual hospitalisation rate of 10·8 per 100 000 inhabitants and an average annual percentage change of 10·4% (95% CI 5·2–15·9). Similarly, Chile had an annual hospitalisation rate of 9·0 per 100 000 inhabitants and an average annual percentage change of 5·9% (4·9–7·0). Interpretation: Hospitalisation rates for IBD are high in western countries but are typically stabilising or decreasing, whereas rates in many newly industrialised countries are rapidly increasing, which reflects the known increase in IBD prevalence in these countries. Potential explanations for these trends include changes in the epidemiology of IBD, health-care delivery, and infrastructure in these countries, as well as overall country-specific patterns in hospitalisations and differences between countries in data collection methods. Funding: None.

Published
2019

35. Mo2000 – Incidence of Celiac Disease is Increasing Over Time: A Systematic Review and Meta-Analysis

Author

King, James A., primary, Jeong, Jocelyn, additional, Underwood, Fox E., additional, Quan, Joshua, additional, Panaccione, Nicola, additional, Windsor, Joseph W., additional, Coward, Stephanie, additional, deBruyn, Jennifer, additional, Ronksley, Paul, additional, Shaheen, Abdel Aziz, additional, Quan, Hude, additional, Godley, Jenny, additional, van Zanten, Sander Veldhuyzen, additional, Lebwohl, Benjamin, additional, Ng, Siew C., additional, and Kaplan, Gilaad, additional

Published
2019
Full Text
View/download PDF

37. Sa1787 – The Progression of Inflammatory Bowel Disease Throughout Latin America: A Systematic Review

Author

Kotze, Paulo G., primary, Underwood, Fox E., additional, Damiao, Aderson O., additional, Ferraz, Jose G., additional, Saad-Hossne, Rogerio, additional, Toro, Martin A., additional, Iade, Beatriz, additional, Padilla, Francisco J. Bosques, additional, Teixeira, Fabio V., additional, Juliao, Fabian, additional, Simian, Daniela, additional, Ghosh, Subrata, additional, Panaccione, Remo, additional, and Kaplan, Gilaad, additional

Published
2019
Full Text
View/download PDF

41. Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific

Author

Ng, Siew C., primary, Kaplan, Gilaad G., additional, Tang, Whitney, additional, Banerjee, Rupa, additional, Adigopula, Bhargavi, additional, Underwood, Fox E., additional, Tanyingoh, Divine, additional, Wei, Shu-Chen, additional, Lin, Wei-Chen, additional, Lin, Hung-Hsin, additional, Li, Jin, additional, Bell, Sally, additional, Niewiadomski, Olga, additional, Kamm, Michael A., additional, Zeng, Zhirong, additional, Chen, Minhu, additional, Hu, Pinjin, additional, Ong, David, additional, Ooi, Choon Jin, additional, Ling, Khoon-Lin, additional, Miao, Yinglei, additional, Miao, Jiarong, additional, Janaka de Silva, H., additional, Niriella, Madunil, additional, Aniwan, Satimai, additional, Limsrivilai, Julajak, additional, Pisespongsa, Pises, additional, Wu, Kaichun, additional, Yang, Hong, additional, Ng, Ka Kei, additional, Yu, Hon Ho, additional, Wang, Yufang, additional, Ouyang, Qin, additional, Abdullah, Murdani, additional, Simadibrata, Marcellus, additional, Gunawan, Jeffri, additional, Hilmi, Ida, additional, Lee Goh, Khean, additional, Cao, Qian, additional, Sheng, Hong, additional, Ong-Go, Arlinking, additional, Chong, Vui Heng, additional, Ching, Jessica Y. L., additional, Wu, Justin C. Y., additional, Chan, Francis K. L., additional, and Sung, Joseph J. Y., additional

Published
2019
Full Text
View/download PDF

42. Effect of IBD medications on COVID-19 outcomes: results from an international registry.

Author

Ungaro, Ryan C., Brenner, Erica J., Gearry, Richard B., Kaplan, Gilaad G., Kissous-Hunt, Michele, Lewis, James D., Ng, Siew C., Rahier, Jean-Francois, Reinisch, Walter, Steinwurz, Flávio, Underwood, Fox E., Xian Zhang, Colombel, Jean-Frederic, and Kappelman, Michael D.

Subjects
COVID-19, NON-communicable diseases, COVID-19 pandemic, DRUGS, MEDICAL personnel
Published
2021
Full Text
View/download PDF

43. Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study

Author

Benchimol,Eric I, Kuenzig,M. Ellen, Bernstein,Charles N, Nguyen,Geoffrey C, Guttmann,Astrid, Jones,Jennifer L, Potter,Beth K, Targownik,Laura E, Catley,Christina A, Nugent,Zoann, Tanyingoh,Divine, Mojaverian,Nassim, Underwood,Fox E, Siddiq,Shabnaz, Otley,Anthony R, Bitton,Alain, Carroll,Matthew W, deBruyn,Jennifer, Dummer,Trevor J.B, El-Matary,Wael, Griffiths,Anne M, Jacobson,Kevan, Leddin,Desmond, Lix,Lisa M, Mack,David R, Murthy,Sanjay K, Peña-Sánchez,Juan Nicolás, Singh,Harminder, Kaplan,Gilaad G, Benchimol,Eric I, Kuenzig,M. Ellen, Bernstein,Charles N, Nguyen,Geoffrey C, Guttmann,Astrid, Jones,Jennifer L, Potter,Beth K, Targownik,Laura E, Catley,Christina A, Nugent,Zoann, Tanyingoh,Divine, Mojaverian,Nassim, Underwood,Fox E, Siddiq,Shabnaz, Otley,Anthony R, Bitton,Alain, Carroll,Matthew W, deBruyn,Jennifer, Dummer,Trevor J.B, El-Matary,Wael, Griffiths,Anne M, Jacobson,Kevan, Leddin,Desmond, Lix,Lisa M, Mack,David R, Murthy,Sanjay K, Peña-Sánchez,Juan Nicolás, Singh,Harminder, and Kaplan,Gilaad G

Abstract

Eric I Benchimol,1–5 M Ellen Kuenzig,1,2,5 Charles N Bernstein,6,7 Geoffrey C Nguyen,5,8 Astrid Guttmann,5,9 Jennifer L Jones,10 Beth K Potter,4 Laura E Targownik,6,7 Christina A Catley,5 Zoann J Nugent,6,11 Divine Tanyingoh,12,13 Nassim Mojaverian,5 Fox E Underwood,12,13 Shabnaz Siddiq,1,2 Anthony R Otley,14 Alain Bitton,15 Matthew W Carroll,16 Jennifer C deBruyn,17 Trevor JB Dummer,18 Wael El-Matary,19 Anne M Griffiths,9 Kevan Jacobson,20,21 Desmond Leddin,10 Lisa M Lix,22 David R Mack,1–3 Sanjay K Murthy,4,23 Juan Nicolás Peña-Sánchez,24 Harminder Singh,6,7 Gilaad G Kaplan12,13 On behalf of the Canadian Gastro-Intestinal Epidemiology Consortium 1Children’s Hospital of Eastern Ontario IBD Centre, Division of Gastroenterology, Hepatology and Nutrition, Children’s Hospital of Eastern Ontario, Ottawa, Canada; 2Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada; 3Department of Pediatrics, University of Ottawa, Ottawa, Canada; 4School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada; 5ICES, Toronto, Canada; 6University of Manitoba IBD Clinical and Research Centre, University of Manitoba, Winnipeg, Canada; 7Department of Internal Medicine, University of Manitoba, Winnipeg, Canada; 8Department of Medicine, Mount Sinai Hospital Centre for Inflammatory Bowel Disease, University of Toronto, Toronto, Canada; 9Department of Paediatrics, University of Toronto, Toronto, Canada; 10Department of Medicine, Dalhousie University, Halifax, Canada; 11CancerCare Manitoba, Winnipeg, Canada; 12Department of Medicine, University of Calgary, Calgary, Alberta, Canada; 13Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; 14Department of Pediatrics, Dalhousie University, Halifax, Canada; 15Division of Gastroenterology, McGill University Health Centre, Montreal, Canada; 16Division of Pediatric Gastroenterology and Nutrition, Dep

Published
2018

44. Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study

Author

Benchimol, Eric I, primary, Kuenzig, M. Ellen, additional, Bernstein, Charles N, additional, Nguyen, Geoffrey C, additional, Guttmann, Astrid, additional, Jones, Jennifer L, additional, Potter, Beth K, additional, Targownik, Laura E, additional, Catley, Christina A, additional, Nugent, Zoann, additional, Tanyingoh, Divine, additional, Mojaverian, Nassim, additional, Underwood, Fox E, additional, Siddiq, Shabnaz, additional, Otley, Anthony R, additional, Bitton, Alain, additional, Carroll, Matthew W, additional, deBruyn, Jennifer, additional, Dummer, Trevor J.B, additional, El-Matary, Wael, additional, Griffiths, Anne M, additional, Jacobson, Kevan, additional, Leddin, Desmond, additional, Lix, Lisa M, additional, Mack, David R, additional, Murthy, Sanjay K, additional, Peña-Sánchez, Juan Nicolás, additional, Singh, Harminder, additional, and Kaplan, Gilaad G, additional

Published
2018
Full Text
View/download PDF

45. Su1835 - Disparities in the Care of Rural and Urban Canadians with Inflammatory Bowel Disease: A Population-Based Study from the Canadian Gastro-Intestinal Epidemiology Consortium

Author

Benchimol, Eric I., primary, Bernstein, Charles N., additional, Nguyen, Geoffrey C., additional, Targownik, Laura E., additional, Guttmann, Astrid, additional, Jones, Jennifer L., additional, Potter, Beth, additional, Kuenzig, Ellen, additional, Catley, Christina, additional, Nugent, Zoann, additional, Tanyingoh, Divine, additional, Mojaverian, Nassim, additional, Underwood, Fox E., additional, and Kaplan, Gilaad, additional

Published
2018
Full Text
View/download PDF

47. Rural and Urban Residence During Early Life is Associated with Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study

Author

Benchimol, Eric I, primary, Kaplan, Gilaad G, additional, Otley, Anthony R, additional, Nguyen, Geoffrey C, additional, Underwood, Fox E, additional, Guttmann, Astrid, additional, Jones, Jennifer L, additional, Potter, Beth K, additional, Catley, Christina A, additional, Nugent, Zoann J, additional, Cui, Yunsong, additional, Tanyingoh, Divine, additional, Mojaverian, Nassim, additional, Bitton, Alain, additional, Carroll, Matthew W, additional, deBruyn, Jennifer, additional, Dummer, Trevor J B, additional, El-Matary, Wael, additional, Griffiths, Anne M, additional, Jacobson, Kevan, additional, Kuenzig, Ellen M, additional, Leddin, Desmond, additional, Lix, Lisa M, additional, Mack, David R, additional, Murthy, Sanjay K, additional, Sánchez, Juan Nicolás Peña, additional, Singh, Harminder, additional, Targownik, Laura E, additional, Vutcovici, Maria, additional, and Bernstein, Charles N, additional

Published
2017
Full Text
View/download PDF

48. Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study

Author

Benchimol, Eric I, primary, Kaplan, Gilaad G, additional, Otley, Anthony R, additional, Nguyen, Geoffrey C, additional, Underwood, Fox E, additional, Guttmann, Astrid, additional, Jones, Jennifer L, additional, Potter, Beth K, additional, Catley, Christina A, additional, Nugent, Zoann J, additional, Cui, Yunsong, additional, Tanyingoh, Divine, additional, Mojaverian, Nassim, additional, Bitton, Alain, additional, Carroll, Matthew W, additional, deBruyn, Jennifer, additional, Dummer, Trevor J B, additional, El-Matary, Wael, additional, Griffiths, Anne M, additional, Jacobson, Kevan, additional, Kuenzig, Ellen M, additional, Leddin, Desmond, additional, Lix, Lisa M, additional, Mack, David R, additional, Murthy, Sanjay K, additional, Sánchez, Juan Nicolás Peña, additional, Singh, Harminder, additional, Targownik, Laura E, additional, Vutcovici, Maria, additional, and Bernstein, Charles N, additional

Published
2017
Full Text
View/download PDF

49. The Global Prevalence of Helicobacter Pylori : A Systematic Review and Meta-Analysis of Population-Based Studies from 1970 to 2016

Author

Ng, Wee khoon, primary, Hooi, James, additional, Lai, Lily, additional, Suen, Michael, additional, Underwood, Fox E., additional, Tanyingoh, Divine, additional, Graham, David Y., additional, Wu, Justin C., additional, Wong, Vincent, additional, Chan, Francis K., additional, Sung, Joseph J., additional, Kaplan, Gilaad, additional, and Ng, Siew C., additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results